Translational Cancer Research
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
Former Australian of the Year Richard Scolyer's 'final farewell'
Open letter from Richard Scolyer released following death Mon 8 Jun 2026 at 6:14am An open letter from former Australian of the Year Richard Scolyer to "All Australians" has been released following his death last night. The renowned pathologist and melanoma researcher was diagnosed with an aggressive form of brain cancer in 2023. He was given just six to eight months to live, but managed to stave off the disease for almost two years with experimental immunotherapy treatment.
Removing ‘invisibility cloaks’ and safely skipping chemo: new weapons in war on cancer shared at US conference
Drug that stops cancer cells hiding and a breakthrough for pancreatic cancer among highlights from Asco conference – but there were also notes of cautionDoctors, scientists and researchers shared new research about ways to tackle cancer at the 2026 American Society of Clinical Oncology (Asco) annual meeting, the world’s largest cancer conference. The event in Chicago, attended by 40,000 health professionals, featured more than 200 sessions and 2,700 poster presentations on this year’s theme,...
Removing ‘invisibility cloaks’ and safely skipping chemo: new weapons in war on cancer shared at US conference
Drug that stops cancer cells hiding and a breakthrough for pancreatic cancer among highlights from Asco conference – but there were also notes of cautionDoctors, scientists and researchers shared new research about ways to tackle cancer at the 2026 American Society of Clinical Oncology (Asco) annual meeting, the world’s largest cancer conference. The event in Chicago, attended by 40,000 health professionals, featured more than 200 sessions and 2,700 poster presentations on this year’s theme,...
Organoid-based colorectal tumor microenvironment model for immuno-oncology research
The development of cancer immunotherapies is hindered by the lack of human-relevant models that accurately translate to patient outcomes. We combine patient-derived colorectal tumor organoids (PDOs) and cancer-associated fibroblasts (CAFs) into floating extracellular matrix drops to form miniature colorectal tumors. These SHaking Organoid COcultures (SHOCOs) maintain immune cells in numbers, states and functional interactions that are more physiologically accurate than traditional PDO-based...
Expedition to Antarctica advances research on potential melanoma treatment
Expedition to Antarctica advances research on potential melanoma treatment Lisa Lock Scientific Editor Andrew Zinin Lead Editor Deep beneath the icy waters surrounding Antarctica, a small marine organism may hold clues to a future cancer treatment. Researchers from USF recently returned from a six-week expedition in one of the most remote environments on Earth to study a species of ascidian, or sea squirt, that contains a bacterium capable of killing melanoma cancer cells. The discovery was...
Pancreatic cancer: New drug extends lives but isn't a cure
Pancreatic cancer: New drug extends lives but isn't a cure June 8, 2026Pancreatic cancer is notoriously difficult to treat — and in many cases leads to death just months after diagnosis. So it is no surprise that this headline created a stir: In a recent study, a new drug, daraxonrasib, was able to double the survival time of patients with pancreatic cancer. Compared with patients who underwent chemotherapy, those treated with daraxonrasib not only lived longer, but also reported a better...
A prognostic human brain network for diffuse midline glioma
Abstract Diffuse midline gliomas (DMGs) are near-universally lethal tumours of the childhood central nervous system1,2. In animal models, DMGs form brain-wide integrated networks through neuron-to-glioma synapses3,4,5,6 and glioma-to-glioma gap junctional coupling3. This extensive connectivity robustly promotes the growth and invasion of DMG3,4,5,6,7,8,9 and other glial malignancies10,11,12 through paracrine mechanisms and direct neuron-to-glioma synapses.
The world will be 100 million cancer workers short by 2050, according to Lancet
A new report warns the world is heading towards a cancer care crisis, with cases sharply rising and the workforce failing to keep pace. The world will need nearly 100 million more cancer workers by 2050, a new study warns. The largest gaps will be among nurses and diagnostic specialists, particularly radiologists and pathologists, with Africa and Asia set to be the hardest hit.
A single protein may be holding back CAR T cancer therapy
A single protein may be holding back CAR T cancer therapy - Date: - June 2, 2026 - Source: - University Hospital Tübingen - Summary: - A newly identified protein may be one of the biggest obstacles holding CAR T-cell therapy back. Researchers found that NFIL3 causes these engineered immune cells to become exhausted and lose their cancer-fighting power over time. When NFIL3 was disabled, the cells remained stronger for longer and controlled tumors more effectively in animal models.
AI brews a caffeine-powered safety switch for future cell therapies
AI brews a caffeine-powered safety switch for future cell therapies Gaby Clark Scientific Editor Robert Egan Associate Editor For many of us, a warm cup of coffee is how we start our day. For Texas A&M Health researchers, it may also offer a new way to control engineered cells in future medicines. A team at the Texas A&M Health Institute of Biosciences and Technology has developed an artificial intelligence-designed molecular switch that uses caffeine to rapidly separate engineered proteins...